Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax

Leukemia

Volumn 21, Issue 2, 2007, Pages 261-269

  Darwiche, N ^a   Abou Lteif, G ^a   Bazarbachi, A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASE 8; CASPASE 9; CERAMIDE; CYTOCHROME C; DITHIOTHREITOL; FENRETINIDE; PLACEBO; REACTIVE OXYGEN METABOLITE; TAX PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CONTROLLED STUDY; DRUG SENSITIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 33846549131     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404472     Document Type: Article

References (31)

1. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F et al. N-(4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 1993; 53: 6036-6041.
2. Bazarbachi A, Hermine O. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res 2001; 78: 79-92.
3. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-496.
4. Kfoury Y, Nasr R, Hermine O, de The H, Bazarbachi A. Proapoptotic regimes for HTLV-I-transformed cells: Targeting Tax and the NF-kappaB pathway. Cell Death Differ 2005; 12: 871-877.
5. Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de The H, El-Sabban ME et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5: 664-672.
6. Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G et al. N-(4-hydroxyphenyl) retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells. Leukemia 2004; 18: 607-615.
7. Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 1997; 89: 1191-1198.
8. DiPietrantonio AM, Hsieh TC, Juan G, Traganos F, Darzynkiewicz Z, Wu JM. Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res 2000; 60: 4331-4335.
9. Hail Jr N, Lotan R. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl) retinamide-induced apoptosis. Cancer Epidemiol Biomarkers Prev 2000; 9: 1293-1301.
10. Darwiche N, Abou-Lteif G, Najdi T, Kozhaya L, Abou Tayyoun A, Bazarbachi A et al. Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide. Biochem J 2005; 392: 231-239.
11. Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK, Lotan R. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 1999; 18: 6380-6387.
12. Boya P, Morales MC, Gonzalez-Polo RA, Andreau K, Gourdier I, Perfettini JL et al. The chemopreventive agent N-(4-hydroxyphenyl) retinamide induces apoptosis through mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 2003; 22: 6220-6230.
13. Ulukaya E, Pirianov G, Kurt MA, Wood EJ, Mehmet H. Fenretinide induces cytochrome c release, caspase 9 activation and apoptosis in the absence of mitochondrial membrane depolarisation. Cell Death Differ 2003; 10: 856-859.
14. Darwiche N, El-Sabban M, Bazzi, Nasr R, Al-Hashimi S, Hermine O et al. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells. Hematol J 2001; 2: 127-135.
15. Smith MR, Greene WC. Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J Clin Invest 1991; 88: 1038-1042.
16. Hatoum A, El-Sabban ME, Khoury J, Yuspa SH, Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001; 22: 1955-1963.
17. Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 6939-6942.
18. Wu JM, DiPietrantonio AM, Hsieh TC. Mechanism of fenretinide (4-HPR)-induced cell death. Apoptosis 2001; 6: 377-388.
19. Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M et al. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood 1999; 93: 1045-1061.
20. Kawakami A, Nakashima T, Sakai H, Urayama S, Yamasaki S, Hida A et al. Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation. Blood 1999; 94: 3847-3854.
21. Satoh E, Okada M, Takadera T, Ohyashiki T. Glutathione depletion promotes aluminum-mediated cell death of PC12 cells. Biol Pharm Bull 2005; 28: 941-946.
22. Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis 1997; 18: 943-948.
23. Hail Jr N, Lotan R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl) retinamide. J Biol Chem 2001; 276: 45614-45621.
24. Sun SY, Yue P, Lotan R. Induction of apoptosis by N-(4-hydroxyphenyl) retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Mol Pharmacol 1999; 55: 403-410.
25. Barna G, Sebestyen A, Weischede S, Petak I, Mihalik R, Formelli F et al. Different ways to induce apoptosis by fenretinide and alltrans-retinoic acid in human B lymphoma cells. Anticancer Res 2005; 25: 4179-4185.
26. Lovat PE, Corazzari M, Goranov B, Piacentini M, Redfern CP. Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells. Ann N Y Acad Sci 2004; 1028: 81-89.
27. Kim DG, You KR, Liu MJ, Choi YK, Won YS. GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells. J Biol Chem 2002; 277: 38930-38938.
28. Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-Hydroxyphenyl) retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene 2006; 25: 2785-2794.
29. Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: Cellular signaling through NF-kappa B. Cytokine Growth Factor Rev 2001; 12: 207-217.
30. Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R et al. p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood 1996; 88: 1551-1560.
31. Kawata S, Ariumi Y, Shimotohno K. p21(Waf1/Cip1/Sdi1) prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded tax. J Virol 2003; 77: 7291-7299.